BIORCHESTRA Invited to Present Update on Central Nervous System Lead Program (BMD-001) and IV-Formulated siRNA Data at BIO2023 International Conference

/PRNewswire/ -- BIORCHESTRA, a biotherapeutics company focused on the treatment of rare and degenerative diseases within the Central Nervous System (CNS),...

Related Keywords

Massachusetts ,United States ,Boston ,New York ,Japan ,Daejeon ,Taejon Gwangyoksi ,South Korea ,Cambridge ,Cambridgeshire ,United Kingdom ,Nanomedicine Btri ,Rockefeller Plaza ,Scott Powell ,Branden Ryu ,Skyline Corporate Communications Group ,Co Ltd ,International Convention ,Twitter ,Linkedin ,Biotechnology Innovation Organization International Convention ,Business Forum ,Achieving Intravenous ,Central Nervous System ,Chief Executive Officer ,Innovation Organization International ,Ribonucleic Acid Interference ,Investigational New Drug ,Amyotrophic Lateral Sclerosis ,Chief Medical Officer ,Brain Targeting Ribonucleic Acid Interference ,Brain Targeting ,One On Partnering ,Corporate Communications Group ,Biorchestra Co ,Td ,